PharmacyCodes



3-04-00-00651 (Beilstein Handbook Reference) en es it fr

3-04-00-00651 (Beilstein Handbook Reference) Brand names, 3-04-00-00651 (Beilstein Handbook Reference) Analogs

3-04-00-00651 (Beilstein Handbook Reference) Brand Names Mixture

  • No information avaliable

3-04-00-00651 (Beilstein Handbook Reference) Chemical_Formula

C5H14N1O1

3-04-00-00651 (Beilstein Handbook Reference) RX_link

No information avaliable

3-04-00-00651 (Beilstein Handbook Reference) fda sheet

3-04-00-00651 (Beilstein Handbook Reference) msds (material safety sheet)

http://www.jtbaker.com/msds/englishhtml/c4092.htm

3-04-00-00651 (Beilstein Handbook Reference) Synthesis Reference

No information avaliable

3-04-00-00651 (Beilstein Handbook Reference) Molecular Weight

264.166 g/mol

3-04-00-00651 (Beilstein Handbook Reference) Melting Point

113 oC (Boiling point), 244-247 oC MP as chloride salt.

3-04-00-00651 (Beilstein Handbook Reference) H2O Solubility

Soluble

3-04-00-00651 (Beilstein Handbook Reference) State

Liquid

3-04-00-00651 (Beilstein Handbook Reference) LogP

No information avaliable

3-04-00-00651 (Beilstein Handbook Reference) Dosage Forms

No information avaliable

3-04-00-00651 (Beilstein Handbook Reference) Indication

For nutritional supplementation, also for treating dietary shortage or imbalance

3-04-00-00651 (Beilstein Handbook Reference) Pharmacology

This compound is needed for good nerve conduction throughout the CNS (central nervous system) as it is a precursor to acetylcholine (ACh). Choline is also needed for gallbladder regulation, liver function and lecithin (a key lipid) formation. Choline also aids in fat and cholesterol metabolism and prevents excessive fat build up in the liver. Choline has been used to mitigate the effects of Parkinsonism and tardive dyskinesia. Choline deficiencies may result in excessive build-up of fat in the liver, high blood pressure, gastric ulcers, kidney and liver dysfunction and stunted growth.

3-04-00-00651 (Beilstein Handbook Reference) Absorption

No information avaliable

3-04-00-00651 (Beilstein Handbook Reference) side effects and Toxicity

Oral rat LD50: 3400 mg/kg

3-04-00-00651 (Beilstein Handbook Reference) Patient Information

No information avaliable

3-04-00-00651 (Beilstein Handbook Reference) Organisms Affected

Humans and other mammals